Redpoint Investment Management Pty LTD Gilead Sciences, Inc. Transaction History

Redpoint Investment Management Pty LTD

$684 Million
Q3 2022

A detailed history of Redpoint Investment Management Pty LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 30,076 shares of GILD stock, worth $2.66 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

30,076

Previous 31,632 4.92%

Holding current value

$2.66 Million

Previous $1.96 Million 5.12%

% of portfolio

0.27%

Previous 0.23%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$59.54 - $68.01 $92,644 - $105,823	-1,556 Reduced 4.92%	30,076 $1.86 Million
Q2 2022 Jul 08, 2022	SELL	$57.72 - $65.01 $22,395 - $25,223	-388 Reduced 1.21%	31,632 $1.96 Million
Q4 2021 Jan 19, 2022	SELL	$64.88 - $73.64 $104,262 - $118,339	-1,607 Reduced 4.78%	32,020 $2.33 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $28,362 - $30,599	-419 Reduced 1.23%	33,627 $2.35 Million
Q1 2021 Apr 13, 2021	BUY	$60.0 - $68.46 $41,700 - $47,579	695 Added 2.08%	34,046 $2.2 Million
Q4 2020 Jan 13, 2021	BUY	$56.65 - $64.55 $82,992 - $94,565	1,465 Added 4.59%	33,351 $1.94 Million
Q3 2020 Oct 09, 2020	SELL	$62.1 - $78.08 $2.73 Million - $3.43 Million	-43,920 Reduced 57.94%	31,886 $2.02 Million
Q2 2020 Jul 17, 2020	SELL	$72.34 - $84.0 $492,997 - $572,460	-6,815 Reduced 8.25%	75,806 $5.83 Million
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $1.08 Million - $1.38 Million	-17,196 Reduced 17.23%	82,621 $6.18 Million
Q4 2019 Feb 25, 2020	SELL	$61.62 - $67.78 $68,521 - $75,371	-1,112 Reduced 1.1%	99,817 $6.49 Million
Q3 2019 Nov 26, 2019	BUY	$62.51 - $69.0 $255,228 - $281,727	4,083 Added 4.22%	100,929 $6.4 Million
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $384,398 - $431,057	-6,213 Reduced 6.03%	96,846 $6.54 Million
Q4 2018 Feb 05, 2019	SELL	$60.54 - $79.0 $61,811 - $80,659	-1,021 Reduced 0.98%	103,059 $6.45 Million
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $429,960 - $476,045	-6,032 Reduced 5.48%	104,080 $8.04 Million
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $357,294 - $416,769	-5,507 Reduced 4.76%	110,112 $7.8 Million
Q1 2018 Aug 09, 2018	BUY	$72.84 - $88.8 $83,984 - $102,386	1,153 Added 1.01%	115,619 $8.72 Million
Q4 2017 Aug 09, 2018	BUY	$71.15 - $83.52 $8.14 Million - $9.56 Million	114,466	114,466 $8.2 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.

Account

Redpoint Investment Management Pty LTD Gilead Sciences, Inc. Transaction History